SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-003785
Filing Date
2024-02-08
Accepted
2024-02-08 07:19:14
Documents
114
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vnda-20231231.htm   iXBRL 10-K 2190398
2 EX-10.47 vnda12312023ex1047.htm EX-10.47 431761
3 EX-23.1 vnda12312023ex231.htm EX-23.1 2362
4 EX-31.1 vnda12312023ex311.htm EX-31.1 10663
5 EX-31.2 vnda12312023ex312.htm EX-31.2 10513
6 EX-32.1 vnda12312023ex321.htm EX-32.1 6678
7 EX-97 vnda12312023ex97.htm EX-97 26584
13 vnda-20231231_g1.gif GRAPHIC 4652
14 vnda-20231231_g2.jpg GRAPHIC 31890
15 vnda-20231231_g3.gif GRAPHIC 3959
16 vnda-20231231_g4.gif GRAPHIC 8078
17 vnda-20231231_g5.jpg GRAPHIC 77962
18 vnda-20231231_g6.jpg GRAPHIC 181361
  Complete submission text file 0001628280-24-003785.txt   10739145

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vnda-20231231.xsd EX-101.SCH 67852
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vnda-20231231_cal.xml EX-101.CAL 99563
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vnda-20231231_def.xml EX-101.DEF 247557
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vnda-20231231_lab.xml EX-101.LAB 829798
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vnda-20231231_pre.xml EX-101.PRE 544941
116 EXTRACTED XBRL INSTANCE DOCUMENT vnda-20231231_htm.xml XML 1285103
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 24606853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)